1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. BOTULINUM TOXINS MARKET BY PRODUCT TYPE
4.1. Introduction
4.2. Botulinum Toxin Type A
4.3. Botulinum Toxin Type B
5. BOTULINUM TOXINS MARKET BY APPLICATION
5.1. Introduction
5.2. Aesthetic Applications
5.3. Therapeutic Applications
6. BOTULINUM TOXINS MARKET BY END-USER
6.1. Introduction
6.2. Hospitals
6.3. Clinics
6.4. Cosmetic Centers
7. BOTULINUM TOXINS MARKET By Geography
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. United Kingdom
7.4.4. Spain
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Israel
7.5.4. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. Japan
7.6.3. India
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Indonesia
7.6.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Allergan Aesthetics (an AbbVie company)
9.2. Galderma S.A.
9.3. Revance Therapeutics, Inc.
9.4. Ipsen Pharma
9.5. Merz Pharma GmbH & Co. KGaA
9.6. Medytox Inc.
9.7. Hugel, Inc.
9.8. Daewoong Pharmaceutical Co., Ltd.
9.9. US WorldMeds, LLC
9.10. Evolus, Inc.